MondayMay 17, 2021 11:13 am

QualityStocksNewsBreaks – First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Announces Incentive Stock Options

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, announced that it has granted incentive stock options. The options will enable specific directors, officers and consultants to purchase up to 850,000 common shares; the shares will be offered under FEMFF’s incentive stock option plan. According to the announcement, the options will be exercisable for a five-year period at an exercise price of $0.35 per share. All options are subject to Canadian Securities Exchange approval. Part of First Energy objective is to add to its portfolio in a deliberate approach in a way that adds value; currently the company’s…

Continue Reading

MondayMay 17, 2021 11:00 am

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment

Healthtech Solutions (OTC: HLTT), the parent company of Varian Biopharmaceuticals Inc., Medi-Scan Inc. and RevHeart Inc., has announced its appointment of Edward (“Ned”) Swanson, M.D., as its chief executive officer. Dr. Swanson brings a unique background and skillset that is particularly well suited to lead Healthtech, combining scientific, clinical and industry knowledge. He is a co-founder of PolarityTE Inc., a biotech company developing various regenerative tissue products and biomaterials, led by its flagship product SkinTE(R). In his leadership roles with PolarityTE and its subsidiaries, Dr. Swanson gleaned deep industry knowledge and know-how related to company formation, financing, product development, medical…

Continue Reading

MondayMay 17, 2021 10:19 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Opens Flagship Store in Popular Canadian Destination

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the opening of its first Canadian brick-and-mortar store under the PlantX brand in Squamish, British Columbia (the "Squamish Flagship Location"). Per the update, the Squamish Flagship Location showcases a variety of carefully curated grocery and wellness items by popular Canadian and U.S. plant-based brands and aims to increase public engagement and plant-based education. "We are extremely pleased to announce the opening of PlantX's first brick-and-mortar store in beautiful Squamish, British Columbia," said PlantX CEO Julia Frank. "Squamish is a health-oriented town with a thriving vegan community and it is…

Continue Reading

MondayMay 17, 2021 9:58 am

QualityStocksNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) RYAH Medtech Enters Exclusive Agreement with DelleD SAS

RYAH Group’s (CSE: RYAH) wholly owned subsidiary, RYAH Medtech Inc., has entered a definitively exclusive software development and product distribution agreement with its France-based partner, DelleD SAS, for the distribution of the RYAH Smart Inhaler. According to the update, the strategic agreement further defines the previously announced arrangement with DelleD to distribute RYAH Smart Inhalers in the territory of France and participate in the upcoming tender for the French government’s national experiment on patient use of medical cannabis. “In addition to distribution of the proprietary devices and accessories, the deal involves a statement of work (‘SOW’) for RYAH to develop customized…

Continue Reading

FridayMay 14, 2021 3:03 pm

QualityStocksNewsBreaks – Infobird Co. Ltd.’s (NASDAQ: IFBD) New SaaS Model Designed to Expand Customer Base, Capture More Market Share

Infobird (NASDAQ: IFBD), a leading artificial intelligence (“AI”) software-as-a-service (“SaaS”) provider is positioned for opportunity amid a wave of digital transformation sweeping across China. In the last two decades, the company has gleaned tremendous experience and achieved significant technological advances and service capabilities while providing customized SaaS products to some of China’s largest and most demanding financial institutions. With that solid foundation in place, Infobird recently implemented a strategic transition to standardized module SaaS with the intent to expand its customer base and quickly capture additional market share. “Standardized module SaaS has the characteristics of fast scale up and low…

Continue Reading

FridayMay 14, 2021 2:06 pm

QualityStocksNewsBreaks – Wave Life Sciences Ltd. (NASDAQ: WVE) Featured in Mizuho Securities Research Report

Wave Life Sciences (NASDAQ: WVE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “This morning, WVE held its 1Q21 call. We also had the opportunity to catch up with management post the call. The most important takeaway from today's call is that we now have a timeline as to when we can expect at least initial clinical data from Wave's new PN-chemistry based pipeline program(s) -- 2022. It's starting to set up as potentially as a really important year for the company in our view, if they produce multiple datasets, which…

Continue Reading

FridayMay 14, 2021 1:39 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Latest Acquisition Brings in Innovative Team of Experts

Healthtech Solutions (OTC: HLTT), focused on acquiring and investing in strategic cutting-edge health care technological opportunities, is among biotech players that have pivoted to a new model wherein multiple portfolio companies operate under one parent organization. Healthtech’s latest acquisition, Varian Biopharmaceuticals, brings to three the number of subsidiaries under its umbrella. “The acquisition of Varian by Healthtech plays to the strengths of the new portfolio model not only in drug pipeline but also by bringing in experts in an area that could attract additional investment,” reads a recent article. A precision oncology company, Varian specializes in developing atypical protein kinase…

Continue Reading

FridayMay 14, 2021 1:33 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Focuses ‘Covid-ID Lab’ Commercialization Strategy Initially on German Market

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently entered a strategic distribution, storage and logistics agreement for its commercial 25-minute COVID-19 RT-PCR test system (“Covid-ID Lab”). In April, XPhyto announced its entry into the agreement with a full-fledged German pharmaceutical wholesaler and service provider. Under the agreement, the German partner will distribute, store and deliver Covid-ID Lab test kits to XPhyto’s customers in line with product specifications and relevant logistical and regulatory requirements in Germany. A recent article quotes XPhyto CEO and Director Hugh Rogers, who noted that the company had secured a strong partner…

Continue Reading

FridayMay 14, 2021 1:02 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Radically Different Cultivation Approach

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) has sought to differentiate itself by focusing on a genetics-based cultivation approach that enables production of premium-quality strains and products. This focus is influenced by the company’s resolution to avoid the fate that has befallen its competitors that have seen recent declines in market share. According to a recent article, PACR’s genetics-based cultivation approach has allowed it “to produce 50 super-elite strains and roughly 350 tested cultivars, which in turn has resulted in the company maximizing yields, boosting profitability and minimizing labor costs. In fact, as Pac Roots CEO explained, the company’s…

Continue Reading

FridayMay 14, 2021 12:37 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Collaborating to Potentially Uncover Innovative New Treatment Options

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, recently began a collaboration with JelikaLite in a clinical trial. The clinical trial, which has 30 participants from two New York City locations, is designed to potentially uncover new treatment options to reduce autism symptoms in children. “JelikaLite was launched by medical researchers and practitioners specializing in psychology, neurology and phototherapy. The company has developed an innovative solution to potentially reduce autism symptoms and is developing a home-based system that combines a therapeutic wearable device called Cognilum(TM) with an AI-personalized platform. . . Cognilum delivers treatments…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered